Managed Healthcare Executive May 13, 2022
The partnership will allow international manufacturers to use the technologies for the potential development of COVID-19 vaccines, treatments and diagnostics to benefit people living in low- and middle-income countries.
The National Institutes of Health, or NIH, recently announced their collaboration with the World Health Organization, or WHO, and the Medicines Patent Pool to make COVID-19 health technologies available worldwide.
The announcement was made at the second Global COVID-19 Summit on May 5.
The NIH has licensed 11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the Medicines Patent Pool through WHO’s COVID-19 Technology Access Pool, or C-TAP, according to an article from HealthcareFinance.
These licenses will allow international manufacturers to use the technologies for the potential development of...
Today's Sponsors
Today's Sponsor